Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice

Journal of Cellular Biochemistry

Volumn 103, Issue 6, 2008, Pages 1975-1988

  Naganawa, Takahiro ^a   Xiao, Liping ^a   Coffin, J D ^b   Doetschman, Thomas ^c   Sabbieti, Maria Giovanna ^d   Agas, Dimitrios ^d   Hurley, Marja M ^a,e  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF MONTANA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF CAMERINO   (Italy)

^e UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

BMP 2; Fgf2 null mice; MAPKinase; Osteoblast

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE ATROPHY; BONE GROWTH; BONE MINERALIZATION; CALVARIA; ENZYME ACTIVITY; GENOTYPE; MOUSE; NEWBORN; NONHUMAN; NULL CELL; OSSIFICATION; OSTEOCLAST; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; STROMA;

ALKALINE PHOSPHATASE; ANIMALS; ANIMALS, NEWBORN; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FIBROBLAST GROWTH FACTOR 2; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOGENESIS; PHOSPHORYLATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SKULL; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 41849139669     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21589     Document Type: Article

References (52)

1. Balint E, Lapointe D, Drissi H, van derMeijden C, Young DW, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2003. Phenotype discovery by gene expression profiling of biological processes linked to mediated osteoblast differentiation. J Cell Biochem 89:401-426.
2. Banergee C, McCabe LR, Choi JY, Hiebert SW, Stein JL, Stein GS, Lian JB. 1997. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 66:1-8.
3. Brunner G, Gabrilove J, Rifkin DB, Wilson EL. 1991. Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol anchored heparan sulfate proteoglycan. J Cell Biol 114:1275-1283.
4. Canalis E, Centrella M, McCarthy T. 1988. Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 8:1572-1577.
5. Canalis E, Economides AR, Gazzerro E. 2003. Bone morphogenetic proteins, their antagonist and the skeleton. Endocrine Rev 24:218-235.
6. Chen D, Harris MA, Rossini G, Dunstan CR, Dallas SL, Feng JQ, Mundy GR, Harris SE. 1997. Bone morphogenetic 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the Induction of mineralized matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int 60:283-290.
7. Choi K, Kim H, Lee M, Kwon T, Nah H, Furuchi T, Komori T, Nam S, Kim Y, Kim H, Ryoo H. 2005. Runx2 regulates FGF-2-induced BMP-2 expression during cranial bone development. Dev Dyn 233:115-121.
8. Dong M, Guda K, Nambiar PR, Nakanishi M, Lichtler AC, Nishikawa M, Giardini C, Rosenberg DW. 2004. Azoxymethane-induced preadipocyte factor 1 (Pref-1) functions as a differentiation inhibitor in colonic epithelial cells. Carcinogenesis 25:2239-2246.
9. Ducy P, Zhang R, Geoffroy V, Ridall A, Karsenty G. 1997. Osf2/cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
10. Dunstan CR, Boyce BF, Garrett IR, Izbicka E, Burgess WH, Mundy GR. 1999. Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J Bone Miner Res 14:953-959.
11. Gallea S, Lallemand F, Atfi A, Rawadi SG, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S. 2001. Activation of mitogen-activated protein kinase cascade in regulation of bone morphogenetic protein-2 induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28:491-498.
12. Globus RK, Patterson-Buckendahl P, Gospodarowicz D. 1998. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor. Endocrinology 123:98-105.
13. Gori F, Thomas T, Hicock KC, Spelsberg TC, Riggs BL. 1999. Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment and inhibits late adipocyte maturation. J Bone Miner Res 14:1522-1535.
14. Gospodarowicz D. 1990. Basic science and pathology fibroblast growth factor chemical structure and biologic function. Clin Orthop Rel Res 257:231-248.
15. Hanada K, Dennis JE, Caplan A. 1997. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein 2 on osteogenic differentiation of rat bone marrow derived mesenchymal stromal cells. J Bone Miner Res 12:1606-1614.
16. Hurley MM, Abreu C, Harrison JR, Lichtler A, Raisz LG, Kream BE. 1993. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J Biol Chem 268:5588-5593.
17. Hurley MM, Marcello K, Abreu C, Kessler M. 1996. Signal transduction by basic fibroblast growth factor in rat osteoblastic Py1a cells. J Bone Miner Res 11:1256-1263.
18. Hurley MM, Lee SK, Marcello K, Abreu C, Raisz LG, Bernecker P. 1998. Basic fibroblast growth factor induces osteoclastogenesis in bone marrow cultures by a prostaglandin-mediated mechanism. Bone 22:309-316.
19. Hurley MM, Marie P, Florkiewicz R. 2002. Fibroblast growth factor and fibroblast growth factor receptor families. In: Bilezikian JP, Raisz LG, Rodan G, editors. Principles of bone biology. San Diego: Academic Press, pp 825-852.
20. Ji C, Casinghino S, Chang DJ, Chen Y, Javed A, Ito Y, Hiebert SW, Lian JB, Stein GS, McCarthy TG, Centrella M. 1998. CBFa (AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem 69:353-363.
21. Kanatani N, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K. 1995. Stimulatory effect of bone morphogenetic 2 enhances osteoclast formation and bone resorbing activity. J Bone Miner Res 10:1681-1690.
22. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766.
23. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM. 2003. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278:319-326.
24. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi Y, Shimizu R, Bronson T, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
25. Kuo P, Hsu Y, Chang CH, Chang JK. 2005. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase pathway in human osteoblast cells. J Pharm Exp Ther 314:1290-1299.
26. Liang H, Pun S, Wronski TJ. 1999. Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats. Endocrinology 140:5780-5788.
27. Locklin RM, Williamson MC, Beresford JN, Triffitt JT, Owen ME. 1995. In vitro effects of growth factors and dexamethasone on rat marrow stromal cells. Clin Orthop Rel Res 313:27-35.
28. Mayahara H, Ito T, Nagai H, Miyajima H, Tsukada R, Takatomi S, Mizoguchi J, Kato K. 1993. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9:73-80.
29. McCarthy TL, Centrella M, Canalis E. 1989. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology 125:2118-2126.
30. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest. 105:1085-1093.
31. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole, WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779.
32. Nagai H, Tsukuda R, Mayahara H. 1995. Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats. Bone 16:367-373.
33. Naganawa T, Xiao L, Abogunde E, Sobue T, Kalajzic I, Sabbieti M, Agas D, Hurley MM. 2006. In vivo and in vitro comparison of the effects of Fgf2 null and haploinsufficiency on bone formation in mice. Biochem Biophys Res Commun 339:490-498.
34. Nakamura T, Hanada K, Tamura M, Shibanushi T, Nigi H, Tagawa M, Fukumoto S, Matsumoto T. 1995. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136:1276-1284.
35. Nakamura K, Kawaguchi H, Aoyama I, Hanada K, Hiyami Y, Awa T, Tamura M, Kurokawa T. 1998. Stimulation of bone formation by intraosseous injection of basic fibroblast growth factor in ovariectomized rats. Int Orthop 22:49-54.
36. Okada Y, Montero A, Zhang X, Sobue T, Lorenzo J, Doetschman T, Coffin JD, Hurley MM. 2003. Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone. J Biol Chem 278:21258-21266.
37. Oliver LJ, Rifkin DB, Gabrilove J, Hannocks MJ, Wilson EL. 1990. Long-term culture of human bone marrow stromal cells in the presence of basic fibroblast growth factor. Growth Factors 3:231-236.
38. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen DR, Selby PB, Ownen MG. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
39. Reddi AH, Huggins C. 1972. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci USA 69:1601-1605.
40. Rodan SB, Wesolowski G, Yoon K, Rodan GA. 1989. Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin and type I collagen mRNA levels in ROS 17/2.8 cells. J Biol Chem 264:19934-19941.
41. Rosen V, Wozney JM. 2002. Bone morphogenetic proteins. Belizikian J, Raisz LG, Rodan G, editors. Principles of bone biology. 2nd edition. San Diego: Academic Press. pp 919-928.
42. Specter JA, Mathy JA, Warren SM, Nacamuli RP, Song HM, Lenton K, Fong KD, Fand DT. 2004. FGF-2 acts through an ERK1/2 intracellular pathway to affect osteoblast differentiation. Plast Reconstr Surg 115:838-852.
43. Thomson BM, Bennett J, Dean V, Triffit J, Miekle MC, Loveridge N. 1993. Preliminary characterization of porcine bone marrow stromal cells: Skeletogenic potential, colony-forming activity, and response to dexamethasone, transforming growth factor beta and basic fibroblast factor. J Bone Miner Res 10:1173-1183.
44. Urist MR. 1965. Bone: Formation by autoinduction. Science 150:893-899.
45. Wozney JM. 1992. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 3:160-167.
46. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT. 2002. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx-2. J Biol Chem 277:36181-36187.
47. Xiao L, Naganawa T, Obugunde E, Gronowicz G, Ornitz DM, Coffin JD, Hurley MM. 2004. Stat1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J Biol Chem 279:27743-27752.
48. Xu X, Weinstein M, Li C, Deng CX. 1999. Fibroblast growth factor receptors (FGFRs) and their role in limb development. Cell Tissue Res 296:33-43.
49. Yamaguchi A. 1995. Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-beta superfamily. Semin Cell Biol 6:165-173.
50. Zhang X, Sobue T, Hurley MM. 2002. FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cells. Biochem Biophys Res Commun 290:526-531.
51. Zhao M, Harris SE, Horn D, Geng Z, Nishimura R, Mundy GR, Chen D. 2002. Bone morphogenetic protein receptor signaling is necessary for murine postnatal bone formation. J Cell Biol 157:1049-1060.
52. Zhou M, Sutliff RL, Paul RJ, Lorenz JN, Hoying JB, Haundenschild CC, Moying Y, Coffin JD, Kong L, Kranias EG, Luo W, Boivin GP, Duffy JJ, Pawlowski SA, Doetschman T. 1998. Fibroblast growth factor 2 control of vascular tone. Nat Med 4:201-207.